BAFNA PHARMACEUTICALS
|
BAFNA PHARMACEUTICALS Last 5 Year Cashflow Statement History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Profit Before Tax | ₹12 Cr | ₹5.19 Cr | ₹5.83 Cr | ₹-1.88 Cr | ₹-18 Cr |
Adjustment | ₹7.88 Cr | ₹5.50 Cr | ₹3.82 Cr | ₹-20 Cr | ₹5.42 Cr |
Changes In working Capital | ₹-15 Cr | ₹-0.80 Cr | ₹-23 Cr | ₹-12 Cr | ₹12 Cr |
Cash Flow after changes in Working Capital | ₹5.08 Cr | ₹9.90 Cr | ₹-14 Cr | ₹-34 Cr | ₹-1.10 Cr |
Cash Flow from Operating Activities | ₹4.95 Cr | ₹9.73 Cr | ₹-14 Cr | ₹-34 Cr | ₹-1.10 Cr |
Cash Flow from Investing Activities | ₹-7.49 Cr | ₹-6.54 Cr | ₹-5.35 Cr | ₹33 Cr | ₹3.53 Cr |
Cash Flow from Financing Activities | ₹10 Cr | ₹-4.81 Cr | ₹12 Cr | ₹7.27 Cr | ₹-2.44 Cr |
Net Cash Inflow / Outflow | ₹7.64 Cr | ₹-1.63 Cr | ₹-6.68 Cr | ₹5.78 Cr | ₹0.00 Cr |
Opening Cash & Cash Equivalents | ₹0.17 Cr | ₹1.80 Cr | ₹8.48 Cr | ₹2.70 Cr | ₹2.70 Cr |
Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
Effect of Foreign Exchange Fluctuations | - | - | - | - | - |
Closing Cash & Cash Equivalent | ₹7.81 Cr | ₹0.17 Cr | ₹1.80 Cr | ₹8.48 Cr | ₹2.70 Cr |
Compare Cashflow Statement of peers of BAFNA PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BAFNA PHARMACEUTICALS | ₹208.6 Cr | -1% | -11.8% | -18% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹356,625.0 Cr | 3% | 2.3% | 68.2% | Stock Analytics | |
CIPLA | ₹112,938.0 Cr | 2.5% | 0.4% | 71.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹101,315.0 Cr | -1.6% | -7% | 23.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,276.9 Cr | -0.2% | -4.9% | 40.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹93,921.9 Cr | 5% | 10.4% | 109.1% | Stock Analytics |
BAFNA PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BAFNA PHARMACEUTICALS | -1% |
-11.8% |
-18% |
SENSEX | 1.3% |
2.6% |
24% |
You may also like the below Video Courses